Rejected at 4:12 a.m. Nov, 01, 2023 ] by Ahmed7
Author: jphillips767
Related Note: 1540499074532 3
Rationale for change

clarity for question needed

Text Text
Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Bootcamp
OME
Additional Resources
Empty field
One by one
Empty field
Changed Tags
mc_use
#AK_Other::step2PotentialDupes::ausername::333more #AK_Step2_v12::#AMBOSS::an0Q7g #AK_Step1_v12::#B&B::16_Neuro::04_Autonomic_Nervous_System::06_Cholinergic_Drugs::Extra #AK_Step2_v12::#Resources_by_rotation::Neuro::ome::dementia #AK_Step2_v12::#Subjects::Neurology::11_Degenerative_Disorders::Alzheimers #AK_Other::Only_Step_2 #AK_Step2_v12::#UWorld::Step::3373 #AK_Step1_v12::#AMBOSS::p2aLiP #AK_Step2_v12::Original_decks::Zanki_Step_2::Neuro::UW_Neuro #AK_Step2_v12::#CMS::Psychiatry::Form_04 #AK_Step2_v12::#OME::02_Neurology::06_Dementia #AK_Step1_v12::#SketchyPharm::06_Neuro_&_Psych::09_Alzheimer's_Medications::01_Alzheimer's_Disease_Medications #AK_Step2_v12::#NBME::Form12 #AK_Step2_v12::#UWorld::COMLEX::100179 #AK_Step1_v12::#Pixorize::03_Pharmacology::02_Cholinomimetics::05_Donepezil_Rivastigmine_&_Galantamine #AK_Step2_v12::#Resources_by_rotation::Neuro::uw::zanki #AK_Step2_v12::!FLAG_THESE_CARDS::Potential_duplicates #AK_Step1_v12::#Bootcamp::Pharmacology::03_Autonomic_System::07_Cholinomimetics_-_Anticholinesterases #AK_Step3_v12::#UWorld::6392 #AK_Step1_v12::#Bootcamp::Neurology::26_Dementia::01_Alzheimer_Dementia #AK_Step2_v12::#AMBOSS::sn0tug #AK_Step2_v12::#CMS::Psychiatry::Form_06 #AK_Step2_v12::Original_decks::Dorian::neuro::ome::dementia #AK_Step2_v12::#Subjects::Neurology::11_Degenerative_Disorders::Alzheimers::Management #AK_Step2_v12::#FirstAid::09_Neuro::12_Neurodegenerative_Disorders::03_Alzheimer_Disease #AK_Step2_v12::Original_decks::Dorian::fam::ome::neuro::dementia #AK_Step1_v12::#AMBOSS::WhaP14 #AK_Other::#AK_Original_Decks::Step_2::Cheesy_Dorian_(M3) #AK_Step1_v12::#NBME::21 #AK_Step2_v12::#AMBOSS::rn0fug #AK_Step1_v12::#OME::Clinical::Neurology::Neurology::Dementia #AK_Step1_v12::#Physeo::09_Pharm::16_Autonomic_Pharm::10_Indirect_Cholinergic_Agonists #AK_Step2_v12::#Resources_by_rotation::Psych::fapsych::neurocognitive_disorders #AK_Step2_v12::#CMS::FM::Form_02 #AK_Step2_v12::#SketchyNeurology::04_Movement_&_Neurodegenerative_Disorders::01_Dementia::01_Dementias_DDx #PANCE::EOR::Family_med #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step1_v12::#UWorld::COMLEX::26658 #AK_Step2_v12::#Resources_by_rotation::FM::ome::neuro::dementia #AK_Step1_v12::#UWorld::Step::18497 #AK_Step2_v12::Original_decks::Dorian::psych::fapsych::neurocognitive_disorders #AK_Step2_v12::#NBME::Form16::Section_1 #AK_Step2_v12::#SketchyNeurology::04_Movement_&_Neurodegenerative_Disorders::01_Dementia::02_Alzheimer_Disease #AK_Step1_v12::#B&B::16_Neuro::05_Other_Neurology_Topics::08_Dementia #AK_Step2_v12::#B&B::10_Neuro::05_OtherTopics::06_Dementia